- Home
- OKYO vs CEE Comparison
OKYO vs CEE Comparison
Compare OKYO & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- CEE
- Stock Information
- Founded
- OKYO 2007
- CEE 1990
- Country
- OKYO United Kingdom
- CEE Germany
- Employees
- OKYO N/A
- CEE N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- CEE Finance Companies
- Sector
- OKYO Health Care
- CEE Finance
- Exchange
- OKYO Nasdaq
- CEE Nasdaq
- Market Cap
- OKYO 105.5M
- CEE 97.8M
- IPO Year
- OKYO 2022
- CEE N/A
- Fundamental
- Price
- OKYO $2.58
- CEE $15.40
- Analyst Decision
- OKYO Strong Buy
- CEE
- Analyst Count
- OKYO 1
- CEE 0
- Target Price
- OKYO $7.00
- CEE N/A
- AVG Volume (30 Days)
- OKYO 138.5K
- CEE 22.0K
- Earning Date
- OKYO 08-12-2025
- CEE 01-01-0001
- Dividend Yield
- OKYO N/A
- CEE 3.86%
- EPS Growth
- OKYO N/A
- CEE N/A
- EPS
- OKYO N/A
- CEE N/A
- Revenue
- OKYO N/A
- CEE N/A
- Revenue This Year
- OKYO N/A
- CEE N/A
- Revenue Next Year
- OKYO N/A
- CEE N/A
- P/E Ratio
- OKYO N/A
- CEE N/A
- Revenue Growth
- OKYO N/A
- CEE N/A
- 52 Week Low
- OKYO $0.81
- CEE $7.80
- 52 Week High
- OKYO $3.11
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- OKYO 53.50
- CEE 50.83
- Support Level
- OKYO $2.05
- CEE $15.27
- Resistance Level
- OKYO $3.10
- CEE $15.72
- Average True Range (ATR)
- OKYO 0.19
- CEE 0.40
- MACD
- OKYO -0.02
- CEE 0.01
- Stochastic Oscillator
- OKYO 43.48
- CEE 68.31
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.